Fatty liver: a novel component of the metabolic syndrome.
about
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisAssociation of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-AnalysisInsulin resistance in clinical and experimental alcoholic liver diseaseObesity and psychotic disorders: uncovering common mechanisms through metabolomicsCholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammationThe Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver DiseaseYKL-40 is a Protective Biomarker for Fatty Liver in World Trade Center Particulate Matter-Exposed FirefightersAssociation Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III StudyChanges in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob miceCoordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primatesNAFLD and liver transplantation: Current burden and expected challenges.Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study.Hepatic inflammation scores correlate with common carotid intima-media thickness in rats with NAFLD induced by a high-fat diet.Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data.Phosphodiesterase 3B is localized in caveolae and smooth ER in mouse hepatocytes and is important in the regulation of glucose and lipid metabolismTissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D surveyTransient elastography as a screening tool for liver fibrosis in a large hemodialysis populationNOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.The impact of breakfast in metabolic and digestive health.Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. studyNon-alcoholic fatty liver disease and cardiovascular risk.Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome.Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietMRI-determined fat content of human liver, pancreas and kidneyThe Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.Nonalcoholic fatty liver disease and polycystic ovary syndrome.Molecular determinants of the cardiometabolic phenotype.Nonalcoholic fatty liver disease and the heart in children and adolescents.Impact of early growth on postprandial responses in later life.Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet.Anti-diabetic effects of palm fruit juice in the Nile rat (Arvicanthis niloticus).Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease.
P2860
Q26765175-182687F5-F46F-4E57-80A1-9D09D366222FQ26775340-5F4FB2C1-897D-4A21-9A15-5E3C0A7C2EC8Q26798155-6C9048C0-E6E8-4CB6-B640-906C13A43396Q26865988-48496600-FEE3-422E-A6A6-C17E65BE91A9Q27011617-CDEFA472-D7FF-44D6-8752-C5B80B9D730AQ27331466-6A8E430A-068A-45B2-94A3-DE52364DF2BDQ28078754-7CD8D4E8-68B8-4053-B857-CB83B78B01E8Q28388339-C784142F-164A-468A-B104-A610E34918ACQ28391820-E1F6B87F-3ACA-45AD-873D-77403E0B473AQ28476015-609FEE24-368F-423C-BF5C-A22D6F5EE503Q28478084-44BE12AB-05FE-4D45-8EBD-01FC80573D21Q30248646-DC479042-1E77-4B6A-B0F8-9301B1F33376Q30401616-0666ABEE-6246-45BC-98B9-67F4DAC20B5AQ30426480-B9484B29-1E11-4F00-81D1-8F03BECCEBD4Q30435948-D33C4AAD-F462-400B-82DC-98EBEFB9190AQ30622511-C3569C79-2682-4F33-9643-F51947C89441Q33415060-6F658299-55B2-4350-95C4-A2D3567A82E7Q33556288-F017CA18-6BE3-4BC5-A2E5-9D32ACC1C162Q33575324-C8CF0B28-306B-437E-92D3-EBCD15F22599Q33577504-E20BDAAB-94F0-40B9-91BD-0F4EB632CFCAQ33583595-2C295481-DBFD-43BB-B004-E23F52207F68Q33584964-7B5C5310-B617-429B-9415-0C21F43AD369Q33596263-22131EA4-0527-449A-8EC1-CAF676361D88Q33596518-AEA2F4A9-F26A-458E-8674-5C72C1F47498Q33596744-F0A60C3A-EE3A-48D3-9D1E-222F78961BD8Q33706265-1EEC98B2-CC8B-42AA-B826-8EE9B3AF712DQ33724041-B9020B8E-A9D1-4F2B-B551-D493462A0123Q33804734-C4F3457D-D712-4F14-9FD0-E44BB95D9C7DQ33812172-5BCD7302-D453-49DB-B5A2-5420A2E0AD79Q33831711-F4EDC3BC-934A-422A-9E7B-F91B27CA1422Q33858409-2848D3A4-70FC-4302-8DEC-EF42C6EE8B46Q33886930-9A7C64D2-5011-4D34-B10E-401E7B774009Q33921392-C8DA3CFD-812B-4343-9DF7-9D6E84E97413Q33958722-738B888B-35A9-4563-8B89-503D7FD52077Q34014485-B9A93CC5-3782-470C-8B06-A685D9A3A909Q34036290-9E3B3FC1-E49A-46C0-9152-32D3EB746CBAQ34056163-0BD2A524-2065-4800-8418-547D1D364B75Q34122121-636AFA65-F29B-4B82-8179-5D926FDD3104Q34125984-CA5E72CC-BB02-42E8-BC29-CCA91785A3CDQ34140886-87409D25-7CDB-4885-AB4D-BEC8C8A68112
P2860
Fatty liver: a novel component of the metabolic syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Fatty liver: a novel component of the metabolic syndrome.
@en
type
label
Fatty liver: a novel component of the metabolic syndrome.
@en
prefLabel
Fatty liver: a novel component of the metabolic syndrome.
@en
P1476
Fatty liver: a novel component of the metabolic syndrome.
@en
P2093
Anna Kotronen
P356
10.1161/ATVBAHA.107.147538
P407
P577
2007-08-09T00:00:00Z